Juno Therapeutics (JUNO) IPO Continues Higher, Crosses Above $40

Last Friday's IPO for Juno Therapeutics (NASDAQ: JUNO) is continuing hither. After jumping on its debut, shares are up another 14.7% today to $40.04. The IPO priced at $24 and gained 46% on Friday.

You May Also Be Interested In

• Barrick Is Said to Weigh Delaying North America Gold IPO to 2027 - Bloomberg
• Lutnick Says 'we Trust Anthropic' - Axios
• Trump On Iran War: Don't Think It'll Be Much Longer